558 related articles for article (PubMed ID: 25087573)
1. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
2. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
3. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
Caswell DR; Swanton C
BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
[TBL] [Abstract][Full Text] [Related]
4. Tumour heterogeneity and immune-modulation.
Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
[TBL] [Abstract][Full Text] [Related]
5. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
6. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
7. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
Lee AJ; Swanton C
Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
[TBL] [Abstract][Full Text] [Related]
8. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Murtaza M; Dawson SJ; Tsui DW; Gale D; Forshew T; Piskorz AM; Parkinson C; Chin SF; Kingsbury Z; Wong AS; Marass F; Humphray S; Hadfield J; Bentley D; Chin TM; Brenton JD; Caldas C; Rosenfeld N
Nature; 2013 May; 497(7447):108-12. PubMed ID: 23563269
[TBL] [Abstract][Full Text] [Related]
10. The causes and consequences of genetic heterogeneity in cancer evolution.
Burrell RA; McGranahan N; Bartek J; Swanton C
Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
[TBL] [Abstract][Full Text] [Related]
11. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
12. Implications of intratumour heterogeneity for treatment stratification.
Crockford A; Jamal-Hanjani M; Hicks J; Swanton C
J Pathol; 2014 Jan; 232(2):264-73. PubMed ID: 24115146
[TBL] [Abstract][Full Text] [Related]
13. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
14. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
Beckman RA; Loeb LA
Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
[No Abstract] [Full Text] [Related]
15. Cancer and natural selection.
Fillon M
J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
[No Abstract] [Full Text] [Related]
16. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
[TBL] [Abstract][Full Text] [Related]
17. The challenge of intratumour heterogeneity in precision medicine.
Seoane J; De Mattos-Arruda L
J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
[TBL] [Abstract][Full Text] [Related]
18. Constraints in cancer evolution.
Venkatesan S; Birkbak NJ; Swanton C
Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
[TBL] [Abstract][Full Text] [Related]
19. [Tumor heterogeneity and drug resistance of targeted antitumor agents].
He QY
Yao Xue Xue Bao; 2016 Feb; 51(2):197-201. PubMed ID: 29856199
[TBL] [Abstract][Full Text] [Related]
20. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
